Capital.
Expertise.
Impact.GLCE — Montréal-based corporate governance, board of directors, advisory board and executive mentorship advisory for Québec organizations, with pharmaceutical compliance expertise across Canadian, US and European regulations.

Groupe Lévesque Capital et Expertise (GLCE)

We support organizations of all sizes with strategic and expert advisory services at the intersection of entrepreneurship, technology, innovation, cybersecurity, artificial intelligence, corporate governance, and pharmaceutical compliance.

Corporate Governance Entrepreneurship Technology Innovation Cybersecurity Artificial Intelligence CQV Conformity Compliance

How we work with you

GLCE engages with organizations through three distinct formats each tailored to the nature of the mandate and the stage of the organization.

01

Board of Directors

Formal board participation suited to more mature companies, typically with external investors where leadership and ownership are separate. Brings independent judgment, governance rigour, and accountability to organizations navigating complex growth.

  • Independent board member
  • Stakeholder alignment
  • Formal governance structures
02

Advisory Board

The natural first step in formalizing governance, best suited for entrepreneur-led companies where founders are both operators and shareholders. Provides structured strategic guidance without the obligations of a formal board.

  • First governance structure
  • Founder-led companies
  • Strategic guidance without board obligations
03

Mentorship

Personalized one-on-one work with entrepreneurs to identify blind spots, challenge assumptions, and sharpen strategic thinking. Focused on building self-awareness and clarity to make better decisions and lead with confidence.

  • Blind spot identification
  • Strategic clarity
  • Decision-making confidence

Conformity
Compliance

GLCE offers specialized services in validation and conformity for the pharmaceutical and biopharmaceutical industry, aligned with Canadian (Health Canada), US (FDA) and European (EMA) regulatory requirements.

Canada
United States
Europe
CQV
Commissioning, Qualification and Validation
From design qualification to process and cleaning validation, GLCE supports your full CQV lifecycle with documented protocols aligned with GMP expectations.
DQIQOQPQPVCV
Quality Systems
Quality Assurance
Support for pharmaceutical quality systems covering change control, CAPA management, risk assessments, and non-conformity handling.
Change ControlCAPARisk Assessment
GxP
GxP Compliance
Inspection preparation through gap assessments, audit readiness reviews, and targeted remediation plans to address regulatory findings.
Gap Assessment Audit Readiness

Backing the next
generation of innovators

GLCE invests in innovative startups to support their development and maximize their growth potential. More than capital we bring hands-on strategic expertise to every investment.

"Capital and expertise working in concert to accelerate what's possible."
Jean-François Lévesque, Managing Director, GLCE
Bausch Health
Innospera Pharma
Polytechnique Montréal
Repreneuriat Québec
FERIQUE
Anges Québec
Coral Health
Attraction
Zilia
Pricepoint
Paratus Medical
Uptimo Immobilier
Amiral Ventures
UNO Platform
SmartOne.ai
Opalia
Scopia
Half Serious
Nabu Pro
Biolift
Neopharm
PRE
Heyquip
Moving Waldo
Fibrenoire
Electrimat
Obkio
UTM Canada
Deville Technologies
Nexxus Foods
cVert
Fiska
Gridbank

Frequently asked questions

Clear answers to the questions executives, entrepreneurs and pharmaceutical organizations most often ask GLCE.

What is the difference between a board of directors and an advisory board?
A board of directors is a formal governance body with legal authority and fiduciary duties: it oversees management, is accountable to shareholders, and is typically required once leadership and ownership are separate, such as when external investors are involved. An advisory board has no legal authority or fiduciary obligations; it provides structured strategic guidance to leadership on a non-binding basis. For most founder-led companies, an advisory board is the natural first step in formalizing governance, before a full board of directors becomes necessary.
When should a company move from an advisory board to a board of directors?
A company typically moves from an advisory board to a board of directors when ownership and leadership become separate, most often when external investors join the capitalization table and require formal oversight and accountability. Other triggers include rapid scaling, increased regulatory or fiduciary exposure, succession planning, or preparation for a financing round or exit. The advisory board formalizes strategic input early; the board of directors adds the legal authority and governance rigour that mature, investor-backed companies need.
What is an independent board member and when does an organization need one?
An independent board member is a director who has no material relationship with the company, its management, or its major shareholders, allowing them to exercise impartial judgment. They bring objective oversight, governance rigour, and accountability that internal or investor-affiliated directors cannot provide alone. An organization typically needs an independent board member once it has external investors, faces complex growth decisions, or wants to balance the interests of founders, investors, and management around the board table.
What are the C.Dir. and ASC designations?
C.Dir. (Chartered Director, awarded by The Directors College, a joint venture of McMaster University and The Conference Board of Canada) and ASC (Administrateur de sociétés certifié, awarded by the Collège des administrateurs de sociétés) are two recognized professional certifications for corporate directors in Canada. They confirm formal training in governance, fiduciary duties, board oversight, financial literacy, and risk. Jean-François Lévesque holds both the C.Dir. and ASC designations, which signal certified competence in serving effectively on a board of directors.
What is CQV and GxP compliance in the pharmaceutical industry?
CQV stands for Commissioning, Qualification and Validation: the documented process of proving that pharmaceutical facilities, equipment, and processes are installed and operate as intended and consistently produce quality results. It spans design qualification (DQ), installation qualification (IQ), operational qualification (OQ), performance qualification (PQ), process validation (PV), and cleaning validation (CV). GxP compliance refers to adherence to Good Practice regulations (such as GMP, Good Manufacturing Practice) required by regulators including the FDA, Health Canada, and the EMA. GLCE supports clients in both areas through documented protocols, various quality system documentation, gap assessments, audit readiness, and remediation plans.
In which regions does GLCE operate?
GLCE is based in Montréal, Québec. Its governance, board and executive mentorship clients are primarily Québec-based organizations. Its pharmaceutical conformity practice is broader in scope, with regulatory expertise spanning Canadian (Health Canada), US (FDA) and European (EMA) requirements. GLCE works in both English and French.
How does GLCE work with organizations?
GLCE engages through three distinct formats, each suited to the organization's stage. First, board of directors participation, formal governance for mature companies with external investors. Second, advisory boards, structured strategic guidance for founder-led companies taking their first governance step. Third, one-on-one executive mentorship, personalized work with entrepreneurs to identify blind spots and sharpen strategic thinking. In addition, GLCE offers specialized pharmaceutical conformity services as a distinct practice. GLCE also invests in innovative startups across a range of sectors, pairing capital with hands-on strategic expertise.

Let's talk about
your project

Whether you're looking for strategic advice, board expertise, mentorship, or an investment partnership reach out directly.

Jean-François Lévesque
Managing Partner
Adeline Fleury
Pharmaceutical Conformity